• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华盛顿州囚犯获释后的药物过量及物质相关死亡率:2014 - 2019年

Overdose and substance-related mortality after release from prison in Washington State: 2014-2019.

作者信息

O'Connor Allyson W, Sears Jeanne M, Fulton-Kehoe Deborah

机构信息

Department of Health Systems and Population Health, University of Washington, 3980 15th Ave NE, Fourth Floor Box 351621, Seattle, WA 98195, USA.

Department of Health Systems and Population Health, University of Washington, 3980 15th Ave NE, Fourth Floor Box 351621, Seattle, WA 98195, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Box 359116, Seattle, WA 98195-8772, USA; Harborview Injury Prevention and Research Center, Box 359960, 325 Ninth Avenue, Seattle, WA 98104, USA; Institute for Work and Health, Toronto, Ontario, Canada.

出版信息

Drug Alcohol Depend. 2022 Dec 1;241:109655. doi: 10.1016/j.drugalcdep.2022.109655. Epub 2022 Oct 12.

DOI:10.1016/j.drugalcdep.2022.109655
PMID:36283246
Abstract

BACKGROUND

Persons released from prison are at an increased risk of mortality compared to the non-incarcerated population, particularly from drug- and opioid-related overdose. Contributors to overdose mortality vary with changing patterns of substance use and updating overdose and mortality statistics may help focus resources for persons released from prison.

METHODS

In this retrospective cohort study, records for 33,811 people released from Washington State Department of Corrections prisons between 2014 and 2018 were linked to Washington State death records from 2014 to 2019. We calculated post-release mortality rates by cause of death, including overdose and substance-related mortality. Hazard ratios for risk factors for all-cause, non-overdose, and overdose mortality were estimated using Cox proportional hazards regression.

RESULTS

862 deaths were identified among persons released from prison. The all-cause mortality rate was 747 per 100,000 person-years (95 % CI: 699-800), and drug overdose was the leading cause of death (216 per 100,000 person-years; 95 % CI: 190-244). Psychostimulant-related mortality (152 per 100,000 person-years; 95 % CI: 131-177) and opioid-related mortality (138 per 100,000 person-years; 95 % CI: 118-161) were the most prevalent among substance-related causes of death, with the greatest mortality risk occurring within two weeks after release. Older age at most recent release, previous incarceration, and drug-related convictions were significant risk factors for all-cause and overdose mortality within six years after release.

CONCLUSIONS

Psychostimulants were the greatest contributors to substance-related mortality for persons released from Washington State prisons. Greater efforts to prevent psychostimulant- and opioid-related overdose are needed.

摘要

背景

与未被监禁的人群相比,出狱人员的死亡风险更高,尤其是死于与毒品和阿片类药物相关的过量用药。过量用药死亡率的影响因素随物质使用模式的变化而变化,更新过量用药和死亡率统计数据可能有助于为出狱人员集中资源。

方法

在这项回顾性队列研究中,将2014年至2018年间从华盛顿州惩教部监狱释放的33811人的记录与2014年至2019年的华盛顿州死亡记录相链接。我们按死亡原因计算了出狱后的死亡率,包括过量用药和与物质相关的死亡率。使用Cox比例风险回归估计全因、非过量用药和过量用药死亡率的风险因素的风险比。

结果

在出狱人员中确定了862例死亡。全因死亡率为每10万人年747例(95%CI:699 - 800),药物过量是主要死因(每10万人年216例;95%CI:190 - 244)。与精神兴奋剂相关的死亡率(每10万人年152例;95%CI:131 - 177)和与阿片类药物相关的死亡率(每10万人年138例;95%CI:118 - 161)是与物质相关死因中最常见的,最大死亡风险发生在释放后的两周内。最近一次释放时年龄较大、以前曾被监禁以及与毒品相关的定罪是释放后六年内全因和过量用药死亡率的重要风险因素。

结论

精神兴奋剂是华盛顿州监狱出狱人员与物质相关死亡率的最大促成因素。需要加大力度预防与精神兴奋剂和阿片类药物相关的过量用药。

相似文献

1
Overdose and substance-related mortality after release from prison in Washington State: 2014-2019.华盛顿州囚犯获释后的药物过量及物质相关死亡率:2014 - 2019年
Drug Alcohol Depend. 2022 Dec 1;241:109655. doi: 10.1016/j.drugalcdep.2022.109655. Epub 2022 Oct 12.
2
Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.1999 年至 2009 年期间,监禁释放后的死亡率:阿片类药物过量和其他死因、危险因素和时间趋势。
Ann Intern Med. 2013 Nov 5;159(9):592-600. doi: 10.7326/0003-4819-159-9-201311050-00005.
3
Estimated effects of opioid agonist treatment in prison on all-cause mortality and overdose mortality in people released from prison in Norway: a prospective analysis of data from the Norwegian Prison Release Study (nPRIS).挪威监狱中阿片类激动剂治疗对出狱人员全因死亡率和药物过量死亡率的估计影响:基于挪威监狱释放研究(nPRIS)数据的前瞻性分析
Lancet Public Health. 2024 Jul;9(7):e421-e431. doi: 10.1016/S2468-2667(24)00098-7.
4
Clinical risk factors for death after release from prison in Washington State: a nested case-control study.华盛顿州出狱后死亡的临床风险因素:一项巢式病例对照研究。
Addiction. 2016 Mar;111(3):499-510. doi: 10.1111/add.13200.
5
Risk factors for all-cause, overdose and early deaths after release from prison in Washington state.华盛顿州囚犯出狱后全因、过量用药和早期死亡的风险因素。
Drug Alcohol Depend. 2011 Aug 1;117(1):1-6. doi: 10.1016/j.drugalcdep.2010.11.029. Epub 2011 Feb 3.
6
High risk of overdose death following release from prison: variations in mortality during a 15-year observation period.出狱后药物过量死亡的高风险:15年观察期内的死亡率变化
Addiction. 2017 Aug;112(8):1432-1439. doi: 10.1111/add.13803. Epub 2017 Apr 7.
7
Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study.不列颠哥伦比亚省监狱释放后致死性过量用药:回顾性数据链接研究。
CMAJ Open. 2021 Sep 28;9(3):E907-E914. doi: 10.9778/cmajo.20200243. Print 2021 Jul-Sep.
8
Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study.澳大利亚囚犯出狱后死亡率的发生率和危险因素:一项前瞻性队列研究。
Addiction. 2018 May;113(5):937-945. doi: 10.1111/add.14106. Epub 2017 Dec 19.
9
Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data.出狱后阿片类药物致命和非致命过量风险:使用链接行政数据的回顾性队列研究。
J Subst Use Addict Treat. 2023 Apr;147:208971. doi: 10.1016/j.josat.2023.208971. Epub 2023 Feb 10.
10
Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons.超越围墙:费城监狱释放后过量死亡的风险因素。
Drug Alcohol Depend. 2018 Aug 1;189:108-115. doi: 10.1016/j.drugalcdep.2018.04.034. Epub 2018 Jun 5.

引用本文的文献

1
"Trust the process:" NARR Level 3 recovery home approaches to working with criminal legal system-involved residents.“相信这个过程”:叙事三级康复之家与涉及刑事法律系统的居民合作的方法。
Justice Oppor Rehabil. 2025;64(3):179-196. doi: 10.1080/2997965x.2025.2467729. Epub 2025 Feb 24.
2
"Wing leaders" in recovery residences: staff key approaches supporting criminal legal system-involved residents receiving medication for opioid use disorder.康复住所中的“翼领导”:工作人员支持涉及刑事法律系统的居民接受阿片类物质使用障碍药物治疗的关键方法。
Front Public Health. 2025 Mar 31;13:1519469. doi: 10.3389/fpubh.2025.1519469. eCollection 2025.
3
Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: results from a national survey.
美国警察局长对物质使用障碍、芬太尼暴露、过量用药应对及自由裁量权使用的看法:一项全国性调查结果
Health Justice. 2025 Mar 5;13(1):13. doi: 10.1186/s40352-025-00318-8.
4
Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study.基于监狱的降低阿片类药物相关过量死亡风险的干预措施:俄亥俄州参与“治愈社区研究”的各县实施情况示例。
Health Justice. 2024 Dec 5;12(1):48. doi: 10.1186/s40352-024-00307-3.
5
"Catching Chain" With Medicaid: The Impact of Medicaid Access on Opioid Overdose Mortality in Adults Released From State Detention.医疗补助计划中的“关联效应”:医疗补助计划的覆盖范围对从州拘留所释放的成年人阿片类药物过量死亡率的影响
Psychiatr Res Clin Pract. 2024 Jun 6;6(3):94-103. doi: 10.1176/appi.prcp.20230080. eCollection 2024 Fall.
6
Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitioners.刑事法律系统背景下阿片类物质使用障碍的联动促进:研究人员、临床医生和法律从业者入门指南
Health Justice. 2024 Aug 29;12(1):36. doi: 10.1186/s40352-024-00291-8.
7
Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019.2014-2019 年马萨诸塞州立监狱监禁前后阿片类药物使用障碍治疗药物的获取情况。
Drug Alcohol Depend. 2024 Sep 1;262:111392. doi: 10.1016/j.drugalcdep.2024.111392. Epub 2024 Jul 16.
8
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.美国酒精滥用与药物依赖协会/美国成瘾医师协会临床实践指南:兴奋剂使用障碍管理
J Addict Med. 2024;18(1S Suppl 1):1-56. doi: 10.1097/ADM.0000000000001299.
9
Environmental Uncertainty and Substance Use Disorders: A Behavior Analytic Perspective.环境不确定性与物质使用障碍:行为分析视角
Policy Insights Behav Brain Sci. 2023 Mar;10(1):96-103. doi: 10.1177/23727322231152451. Epub 2023 Mar 15.
10
Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes.监狱丁丙诺啡实施和释放后阿片类药物使用障碍结果。
JAMA Netw Open. 2024 Mar 4;7(3):e242732. doi: 10.1001/jamanetworkopen.2024.2732.